Abstract
Migraine is a common disorder that is disproportionately prevalent in women, especially during the reproductive years. Hormonal changes may play a role in the etiology of migraine, as many women note that their migraine attacks occur in temporal relationship with their menses. The Headache Classification Subcommittee of the International Headache Society has recently defined menstrual and menstrually related migraine. We review the most relevant and recent literature on menstrual migraine, with a special focus on pathophysiology and therapy. Although the pathogenesis of menstrual and menstrually related migraine is not well understood, estrogen withdrawal seems to play an important role as a trigger for menstrual migraine attacks. The therapeutic approach also may differ from the treatment of nonmenstrual migraine. Some patients do not require prophylaxis when they can abort their attacks effectively, whereas others may benefit from perimenstrual prophylaxis or standard migraine prophylaxis.
Similar content being viewed by others
References and Recommended Reading
Loder E, Marcus DA: Migraine in Women. Hamilton, Ontario: Decker BC; 2004:102–111.
MacGregor EA: “Menstrual” migraine: towards a definition. Cephalalgia 1996, 16:11–21.
Headache Classification Subcommittee of the International Headache Society (IHS). The International Classification of Headache Disorders (2nd edition). Cephalalgia 2004, 24(Suppl 1):9–160.
Couturier EG, Bomhof MA, Knuistingh Neven A, et al.: Menstrual migraine in a representative Dutch population sample: prevalence, disability and treatment. Cephalalgia 2003, 23:302–308.
Dzoljic E, Sipetic S, Vlajinac H, et al.: Prevalence of menstrually related migraine and nonmigraine primary headache in female students of Belgrade University. Headache 2002, 42:185–193.
Solbach P, Sargent J, Coyne L: Menstrual migraine headache: results of a controlled, experimental, outcome study of non-drug treatments. Headache 1984, 24:75–78.
Somerville BW: The role of progesterone in menstrual migraine. Neurology 1971, 21:853–859.
Somerville BW: The role of estradiol in the etiology of menstrual migraine. Neurology 1972, 22:355–365.
Somerville BW: Estrogen-withdrawal migraine. I. Duration of exposure required and attempted prophylaxis by premenstrual estrogen administration. Neurology 1975, 25:239–244.
Welch KM, Darnley D, Simkins R: The role of estrogen in migraine: a review and hypothesis. Cephalalgia 1984, 4:227–236.
Fioroni L, Martignoni E, Facchinetti F: Changes of neuroendocrine axes in patients with menstrual migraine. Cephalalgia 1995, 15:297–300.
Fioroni L, D’Andrea G, Alecci M, et al.: Platelet serotonin pathway in menstrual migraine. Cephalalgia 1996, 16:427–430.
Brun J, Claustrat B, Saddier P, et al.: Nocturnal melatonin excretion is decreased in patients with migraine without aura associated with menses. Cephalalgia 1995, 15:136–139.
Murialdo G, Fonzi S, Costelli P, et al.: Urinary melatonin excretion throughout the ovarian cycle in menstrually related migraine. Cephalalgia 1994, 14:205–209.
MacGregor EA: Oestrogen and attacks of migraine with and without aura. Lancet Neurol 2004, 3:354–361. This is a recent review of hormonal factors in menstrual migraine.
Massiou H: Is menstrually associated migraine difficult to treat? Cephalalgia 1999, 19(Suppl 24):13–18.
Stewart WF, Lipton RB, Chee E, et al.: Menstrual cycle and headache in a population sample of migraineurs. Neurology 2000, 55:1517–1523.
Mattsson P: Hormonal factors in migraine: a population-based study of women aged 40 to 74 years. Headache 2003, 43:27–35.
Facchinetti F, Neri I, Martignoni E, et al.: The association of menstrual migraine with the premenstrual syndrome. Cephalalgia 1993, 13:422–425.
Gupta VK: Menstrual migraine is not pathogenetically related to premenstrual syndrome. Cephalalgia 1994, 14:411–412.
Facchinetti F: The premenstrual syndrome belongs in the diagnostic criteria for menstrual migraine. Cephalalgia 1994, 14:413–414.
Granella F, Sances G, Allais G, et al.: Characteristics of menstrual and nonmenstrual attacks in women with menstrually related migraine referred to headache centres. Cephalalgia 2004, 24:707–716. This is a study comparing the differences in clinical features and response to abortive therapy of menstrual and non-menstrual migraine.
MacGregor EA, Hackshaw A: Prevalence of migraine on each day of the natural menstrual cycle. Neurology 2004, 63:351–353.
Johannes CB, Linet MS, Stewart WF, et al.: Relationship of headache to phase of the menstrual cycle among young women: a daily diary study. Neurology 1995, 45:1076–1082.
Silberstein SD, Armellino JJ, Hoffman HD, et al.: Treatment of menstruation-associated migraine with the nonprescription combination of acetaminophen, aspirin and caffeine: results from three randomized, placebo-controlled studies. Clin Ther 1999, 21:475–491.
Loder E, Silberstein SD, Abu-Shakra S, et al.: Efficacy and tolerability of oral zolmitriptan in menstrually associated migraine: a randomized, prospective, parallel-group, double-blind, placebo-controlled study. Headache 2004, 44:120–130.
Facchinetti F, Bonellie G, Kangasniemi P, and the Sumatriptan Menstrual Migraine Study Group: The efficacy and safety of subcutaneous sumatriptan in the acute treatment of menstrual migraine. Obstet Gynecol 1995, 86:911–916.
Silberstein SD, Massiou H, Le Jeunne C, et al.: Rizatriptan in the treatment of menstrual migraine. Obstet Gynecol 2000, 96:237–242.
Loder E: Menstrual migraine: timing is everything. Neurology 2004, 63:202–203.
Loder E: Prophylaxis of menstrual migraine with triptans: problems and possibilities. Neurology 2002, 59:1677–1681.
Silberstein SD, Elkind AH, Schreiber C, et al.: A randomized trial of frovatriptan for the intermittent prevention of menstrual migraine. Neurology 2004, 63:261–269.
Newman L, Mannix LK, Landy S, et al.: Naratriptan as short-term prophylaxis of menstrually associated migraine: a randomized, double-blind, placebo-controlled study. Headache 2001, 41:248–256.
ChavanuKJ, O’Donnell DC: Hormonal interventions for menstrual migraines. Pharmacotherapy 2002, 22:1442–1457. This is a thorough review of the literature on hormonal therapy for menstrual migraine, with detailed tables comparing the studies discussed.
Silberstein SD: The role of sex hormones in headache. Neurology 1992, 42(Suppl 2):37–42.
de Lignieres B, Vincens M, Mauvais-Jarvis P, et al.: Prevention of menstrual migraine by percutaneous oestradiol. BMJ 1986, 293:1540.
Smits MG, Meer YG, Pfeil JP, et al.: Perimenstrual migraine: effect of Estraderm TTS (r) and the value of contingent negative variation and exteroceptive temporalis muscle suppression test. Headache 1993, 34:103–106.
MacGregor A: Effects of oral and transdermal estrogen replacement on migraine. Cephalalgia 1999, 19:124–125.
O’Dea JP, Davis EH: Tamoxifen in the treatment of menstrual migraine. Neurology 1990, 40:1470–1471.
Lichten EM, Bennett RS, WhittyAJ, et al.: Efficacy of danazol in the control of hormonal migraine. J Reprod Med 1991, 36:419–424.
Herzog AG: Continuous bromocriptine therapy in menstrual migraine. Neurology 1997, 48:101–102.
Murray SC, Muse KN: Effective treatment of severe menstrual migraine headaches with gonadotropin-releasing hormone agonist and “add-back” therapy. Fertil Steril 1997, 67:390–393.
Martin V, Wernke S, Mandell K, et al.: Medical oophorectomy with and without estrogen add-back therapy in the prevention of migraine headache. Headache 2003, 43:309–321.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Recober, A., Geweke, L.O. Menstrual migraine. Curr Neurol Neurosci Rep 5, 93–98 (2005). https://doi.org/10.1007/s11910-005-0005-4
Issue Date:
DOI: https://doi.org/10.1007/s11910-005-0005-4